Wanda L. Salzer, MD¹, Michael J. Burke, MD^2*, Meenakshi Devidas, PhD, MBA³, Zhiguo (Bruce) Chen, MS^4*, Michael J. Borowitz, MD, PhD⁵, Andrew J Carroll, PhD⁶, I-Ming L. Chen, DVM, MS⁷, Julie M. Gastier-Foster, PhD^8*, Richard C. Harvey, PhD^9*, Nyla A. Heerema, PhD^10*, Charles G. Mullighan, MBBS, MD¹¹, Karen R. Rabin, MD, PhD¹², Shalini C Reshmi, PhD¹³, Cheryl L. Willman, MD^14*, Brent L. Wood, MD, PhD¹⁵, Naomi J. Winick, MD¹⁶, William L. Carroll, MD¹⁷, Elizabeth A. Raetz, MD¹⁸, Mignon L. Loh, MD¹⁹ and Stephen P. Hunger, MD²⁰

¹Uniformed Services University, Bethesda, MD
²The Medical College of Wisconsin Inc, Milwaukee, WI
³St Jude Children's Research Hospital, Memphis, TN
⁴Biostatistics, University of Florida, Gainesville, FL
⁵Johns Hopkins University School of Medicine, Baltimore, MD
⁶Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
⁷University of New Mexico Cancer Rsch Facility, Albuquerque, NM
⁸Nationwide Childrens Hospital Ohio State University, Houston, TX
⁹University of New Mexico School of Medicine, Albuquerque, NM
¹⁰Ohio State University, Columbus, OH
¹¹Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
¹²Department of Pediatrics, Baylor College of Medicine, Baylor College of Medicine TX Children's Cancer Center, Houston, TX
¹³Nationwide Children's Hospital, Columbus, OH
¹⁴Mayo Clinic, Rochester, MN
¹⁵Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
¹⁶Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX
¹⁷Perlmutter Cancer Center, Department of Pediatrics and Pathology, NYU Grossman School of Medicine, New York, NY
¹⁸Department of Pediatrics, NYU Langone Health, New York, NY
¹⁹Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital, Seattle, WA
²⁰Childrens Hospital of Philadelphia, Philadelphia

Nicolas Boissel, MD, PhD^1*, Carlos Graux^2*, Francoise Huguet, MD^3*, Florence Pasquier, MD, PhD^4*, Aurore Touzart, MD, PhD^5*, Thomas Cluzeau, MD, PhD⁶, Ludovic Lhermitte^7*, Eric Delabesse, MD, PhD^8*, Patrice Chevallier, MD⁹, Mathilde Hunault, MD, PhD^10*, Cedric Pastoret, MD^11*, Sebastien Maury^12*, Nathalie Grardel^13*, Martine Escoffre Barbe, MD^14*, Pascal Turlure, MD^15*, Beat Schafer^16*, Marie Balsat, MD^17*, Philippe Rousselot^18*, Thibaut Leguay^19*, Eric Jourdan, MD, PhD^20*, Delphine Pranger^21*, Michael Gregor^22*, Emilie Lemasle, MD^23*, Anne Marie Ronchetti^24*, Ana Berceanu, MD^25*, Ingrid Lafon, MD^26*, Madalina Uzunov, MD^27*, Etienne Lengline^28*, Norbert Ifrah, MD, PhD¹⁰, Yves Chalandon, MD²⁹, Véronique Lhéritier^30*, Vahid Asnafi^31* and Herve Dombret, MD³²

¹Hôpital Saint-Louis, Paris, France
²Department of Hematology, Université catholique de Louvain, CHU UCL Namur - site Godinne, Yvoir, BEL
³IUCT-Oncopole, Toulouse, France
⁴INSERM U790, PR1, IGR, Villejuif, FRA
⁵Institut Necker-Enfants Malades (INEM), Paris, FRA
⁶CHU Nice, Nice, FRA
⁷University Hospital Necker, Necker, Paris, FRA
⁸IUCT-Oncopole, Hematology Laboratory, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
⁹CHU de Nantes - Hôtel Dieu, Nantes, France
¹⁰Hematology Department, CHU Angers, Angers, France
¹¹Rennes University Hospital, RENNES, FRA
¹²Hematology Department, Hôpitaux universitaires Henri Mondor AP-HP & Université Paris Est Créteil, Créteil, France
¹³CHRU De Lille, LILLE, FRA
¹⁴Department of hematology, Rennes, France
¹⁵Service d'Hématologie Clinique, CHU de Limoges, Limoges, France
¹⁶University Children's Hospital, Zurich, CHE
¹⁷Clinical Hematology Department, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France, Lyon, France
¹⁸HôPital André Mignot, Le Chesnay, FRA
¹⁹Hopital Du Haut-Leveque, Pessac, FRA
²⁰Hematology department, Institut de Cancérologie du Gard, CHU de Nîmes, Nimes, France
²¹Grand Hôpital de Charleroi, Charleroi, BEL
²²Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland, Luzern, CHE
²³Hematology Department, Centre Henri Becquerel, Rouen, France
²⁴CH Sud Francilien, Hematology Department, Corbeil Essonne, France
²⁵Department of Clinical Hematology, CHU de Besançon, Besançon, France
²⁶Service d'Hematologie, Institut de Cancérologie de Bourgogne (ICB), Polyclinique du Parc Drevon (Dijon), Dijon, France
²⁷Clinical hematology, Pitie-Salpetriere Hopstal, APHP, Sorbonne Universite, Paris, FRA
²⁸Department of Hematology, Saint Louis University Hospital, AP-HP, PARIS, FRA
²⁹Univ. Hospital of Geneva, Geneva, CHE
³⁰Service d’Hématologie Coordination GRAALL, HCL, Hôpital Lyon Sud, Pierre Bénite, France
³¹Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants, Paris, FRA
³²HôPital Saint-Louis, Assistance Publique - HôPitaux De Paris (AP-H, Paris, FRA

Jayastu Senapati, MD, MBBS, DM¹, Hagop M. Kantarjian, MD¹, Elias Jabbour¹, Rodrick Babakhanlou, MD, MSc^2*, Tapan M. Kadia, MD¹, Gautam Borthakur, MD¹, Marina Y. Konopleva^1,3, William G. Wierda, MD, PhD⁴, Jan A. Burger, MD, PhD ⁵, Ghayas C. Issa⁴, Abhishek Maiti, MD⁵, Hayley S. Balkin^2*, Mary Kelly^2*, Rebecca Garris^1*, Alessandra Ferrajoli, MD¹, Guillermo Garcia-Manero, MD⁴, Yesid Alvarado Valero, MD¹, Partow Kebriaei, MD⁶, Nicholas J. Short, MD¹, Nitin Jain, MD¹ and Farhad Ravandi, MD, MBBS¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
⁴The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁶Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Nicola Goekbuget, MD¹, Stefan Schwartz, MD^2*, Christoph Faul, MD³, Max S. Topp, MD^4*, Marion Subklewe, MD⁵, Andrea Renzelmann, MD^6*, Andrea Stoltefuss, MD^7*, Bernd Hertenstein, MD^8*, Anne Wilke, MD^1*, Simon Raffel, MD^9*, Nadja Jäkel, MD^10*, Vladan Vucinic, M.D.^11*, Dirk Markus Niemann, MD¹², Lena Reiser^1*, Hubert Serve, MD¹³, Monika Brüggemann, MD^14* and Andreas Viardot, MD PhD¹⁵

¹Department of Medicine II, Hematology/Oncology, Goethe University Hospital, Frankfurt, Germany
²Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin) Charité - Universitätsmedizin Berlin, Berlin, Germany
³Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
⁴Department of Internal Medicine II, Hematology and Oncology, University Hospital Wuerzburg, Wuerzburg, Germany
⁵Department of Medicine III, LMU University Hospital, LMU Munich, Muenchen, Bavaria, Germany
⁶Klinikum Oldenburg, Oldenburg, DEU
⁷Evangelisches Krankenhaus, Hamm, DEU
⁸Department of Internal Medicine I, Klinikum Bremen Mitte, Bremen, Germany
⁹Heidelberg University Hospital, Heidelberg, Germany
¹⁰Universitätsklinikum Halle, Halle, Germany
¹¹Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig, Leipzig, Germany
¹²Gemeinschaftsklinikum Mittelrhein Koblenz, Koblenz, Germany
¹³Department of Internal Medicine II, Hematology and Oncology, Goethe University Hospital Frankfurt, Frankfurt, Germany
¹⁴Clinic for Internal Medicine II - Haematology, Oncology, University Clinic Schleswig-Holstein, Kiel, Germany
¹⁵Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany

Marlise R. Luskin, MD¹, Mark Alan Murakami, MD, MA, MMSc², Julia Keating, MS^3*, Eric S. Winer, MD², Jacqueline S. Garcia, MD⁴, Maximilian Stahl, MD⁵, Martha Wadleigh, MD², Yael Flamand, MS^2*, Donna S. Neuberg, ScD³, Ilene Galinsky, ANP⁴, Rebecca Leonard^4*, Ella Hagopian^2*, Chase M Weizer^2*, Carlin McLanahan^6*, Richard M Stone, MD², Eunice S. Wang, MD⁷, Wendy Stock, MD⁸ and Daniel J. DeAngelo²

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁴Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁵Dana Farber Institute, Boston, MA
⁶Dana-Farber Cancer Institute, Boston
⁷Roswell Park Cancer Institute, Buffalo, NY
⁸University of Chicago Medicine, Chicago, IL

Jonathan Allen Webster, MD¹, Marlise R. Luskin, MD², Joseph Rimando, MD³, Amanda Blackford^4*, Amer M. Zeidan, MBBS, MHS⁵, Elad Sharon, MD, MPH^6*, Howard Streicher, MD^7*, Daniel J. DeAngelo⁸, Leo Luznik, MD⁹ and Ivana Gojo, MD¹⁰

¹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD
²Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD, Johns Hopkins University School of Medicine, ATLANTA, GA
⁴Johns Hopkins University, Baltimore, MD
⁵Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT
⁶NCI Cancer Therapy Evaluation program (CTEP), Bethesda, MD
⁷NCI NIH IDB, Rockville, MD
⁸Dana-Farber Cancer Institute, Boston, MA
⁹Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD
¹⁰Johns Hopkins, Baltimore, MD